Skip to main content
Erschienen in: World Journal of Surgery 11/2018

25.04.2018 | Original Scientific Report

Cribriform-Morular Variant of Papillary Thyroid Carcinoma: Clinical and Pathological Features of 30 Cases

verfasst von: Junko Akaishi, Tetsuo Kondo, Kiminori Sugino, Yuna Ogimi, Chie Masaki, Kiyomi Y. Hames, Tomonori Yabuta, Chisato Tomoda, Akifumi Suzuki, Kenichi Matsuzu, Takashi Uruno, Keiko Ohkuwa, Wataru Kitagawa, Mitsuji Nagahama, Ryohei Katoh, Koichi Ito

Erschienen in: World Journal of Surgery | Ausgabe 11/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Cribriform-morular variant of papillary thyroid carcinoma (CMV-PTC) is rare; it may occur in cases of familial adenomatous polyposis (FAP) or be sporadic. To clarify the clinicopathological features of CMV-PTC, the medical records of these patients were investigated retrospectively.

Materials and methods

Between 1979 and 2016, a total of 17,062 cases with PTC underwent initial surgery at Ito Hospital. Of these, 30 (0.2%) cases histologically diagnosed with CMV-PTC were reviewed.

Result

The patients were all women, with a mean age at the time of surgery of 24 years. Seven (23%) cases were thought to have FAP because they had colonic polyposis or a family history of FAP or APC gene mutation. The remaining 23 (77%) were thought to be sporadic. Multiple tumors were detected in 6 cases, with a solitary tumor in 24. One patient had lung metastasis at diagnosis. Eleven patients underwent total thyroidectomy or subtotal thyroidectomy, and 19 underwent lobectomy. Twenty-six (87%) patients underwent neck lymph node dissection. Three patients had tumor metastasis in central lymph nodes, but these were incidentally detected metastatic classical PTC (cPTC) based on histological examination. In this series, there were no cases of LN metastases of CMV-PTC. During a mean follow-up of 15 years, one patient had new cPTC in the remnant thyroid after initial surgery, and the other patients showed no signs of recurrence.

Conclusion

CMV-PTC occurred in young women, their long-term prognosis was excellent. Total thyroidectomy is recommended for FAP-associated CMV-PTC, but modified neck lymph node dissection is not necessary.
Literatur
1.
Zurück zum Zitat Crail HW (1949) Multiple primary malignancies arising in the rectum, brain, and thyroid; report of a case. U S Nav Med Bull 49:123–128PubMed Crail HW (1949) Multiple primary malignancies arising in the rectum, brain, and thyroid; report of a case. U S Nav Med Bull 49:123–128PubMed
2.
Zurück zum Zitat Camiel MR, Mule JE, Alexander LL et al (1968) Association of thyroid carcinoma with Gardner’s syndrome in siblings. N Engl J Med 278:1056–1058CrossRef Camiel MR, Mule JE, Alexander LL et al (1968) Association of thyroid carcinoma with Gardner’s syndrome in siblings. N Engl J Med 278:1056–1058CrossRef
3.
Zurück zum Zitat Yamashita T, Hosoda Y, Kameyama K et al (1992) Peculiar nuclear clearing composed of microfilaments in papillary carcinoma of the thyroid. Cancer 70:2923–2928CrossRef Yamashita T, Hosoda Y, Kameyama K et al (1992) Peculiar nuclear clearing composed of microfilaments in papillary carcinoma of the thyroid. Cancer 70:2923–2928CrossRef
4.
Zurück zum Zitat Harach HR, Williams GT, Williams ED (1994) Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm. Histopathology 25:549–561CrossRef Harach HR, Williams GT, Williams ED (1994) Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm. Histopathology 25:549–561CrossRef
5.
Zurück zum Zitat Hizawa K, Iida M, Yao T et al (1996) Association between thyroid cancer of cribriform variant and familial adenomatous polyposis. J Clin Pathol 49:611–613CrossRef Hizawa K, Iida M, Yao T et al (1996) Association between thyroid cancer of cribriform variant and familial adenomatous polyposis. J Clin Pathol 49:611–613CrossRef
7.
Zurück zum Zitat Cameselle-Teijeiro J, Chan JK (1999) Cribriform-morular variant of papillary carcinoma: a distinctive variant representing the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma? Mod Pathol 12:400–411PubMed Cameselle-Teijeiro J, Chan JK (1999) Cribriform-morular variant of papillary carcinoma: a distinctive variant representing the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma? Mod Pathol 12:400–411PubMed
8.
Zurück zum Zitat Nielsen M, Hes FJ, Nagengast FM et al (2007) Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis. Clin Genet 71:427–433CrossRef Nielsen M, Hes FJ, Nagengast FM et al (2007) Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis. Clin Genet 71:427–433CrossRef
9.
Zurück zum Zitat Lloyd RV, Osamura RY, Klöppel G, et al (2017) WHO Classification of Tumours of Endocrine Organs WHO/IARC Classification of Tumours, 4th edn. International Agency for Research on Cancer Lloyd RV, Osamura RY, Klöppel G, et al (2017) WHO Classification of Tumours of Endocrine Organs WHO/IARC Classification of Tumours, 4th edn. International Agency for Research on Cancer
10.
Zurück zum Zitat Sobin L, Gospodarowicz M, Wittekind C (2009) Union for International Cancer Control classification system TNM Classification of malignant tumors, 7th edn. Wiley, Hoboken Sobin L, Gospodarowicz M, Wittekind C (2009) Union for International Cancer Control classification system TNM Classification of malignant tumors, 7th edn. Wiley, Hoboken
11.
Zurück zum Zitat Ito Y, Miyauchi A, Ishikawa H et al (2011) Our experience of treatment of cribriform morular variant of papillary thyroid carcinoma; difference in clinicopathological features of FAP-associated and sporadic patients. Endocr J 58:685–689CrossRef Ito Y, Miyauchi A, Ishikawa H et al (2011) Our experience of treatment of cribriform morular variant of papillary thyroid carcinoma; difference in clinicopathological features of FAP-associated and sporadic patients. Endocr J 58:685–689CrossRef
12.
Zurück zum Zitat Levy RA, Hui VW, Sood R et al (2014) Cribriform-morular variant of papillary thyroid carcinoma: an indication to screen for occult FAP. Fam Cancer 13:547–551CrossRef Levy RA, Hui VW, Sood R et al (2014) Cribriform-morular variant of papillary thyroid carcinoma: an indication to screen for occult FAP. Fam Cancer 13:547–551CrossRef
14.
Zurück zum Zitat Hirokawa M, Kuma S, Miyauchi A et al (2004) Morules in cribriform-morular variant of papillary thyroid carcinoma: immunohistochemical characteristics and distinction from squamous metaplasia. APMIS 112:275–282CrossRef Hirokawa M, Kuma S, Miyauchi A et al (2004) Morules in cribriform-morular variant of papillary thyroid carcinoma: immunohistochemical characteristics and distinction from squamous metaplasia. APMIS 112:275–282CrossRef
15.
Zurück zum Zitat Fujimoto T, Hirokawa M, Ota H et al (2015) Characteristic sonographic features of cribriform papillary thyroid carcinoma for differentiation from other thyroid nodules. J Med Ultrason 2001 42:83–87CrossRef Fujimoto T, Hirokawa M, Ota H et al (2015) Characteristic sonographic features of cribriform papillary thyroid carcinoma for differentiation from other thyroid nodules. J Med Ultrason 2001 42:83–87CrossRef
16.
Zurück zum Zitat Bulow C, Bulow S (1997) Is screening for thyroid carcinoma indicated in familial adenomatous polyposis? The Leeds Castle Polyposis Group. Int J Colorectal Dis 12:240–242CrossRef Bulow C, Bulow S (1997) Is screening for thyroid carcinoma indicated in familial adenomatous polyposis? The Leeds Castle Polyposis Group. Int J Colorectal Dis 12:240–242CrossRef
17.
Zurück zum Zitat Iwama T, Mishima Y, Utsunomiya J (1993) The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment. Ann Surg 217:101–108CrossRef Iwama T, Mishima Y, Utsunomiya J (1993) The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment. Ann Surg 217:101–108CrossRef
18.
Zurück zum Zitat Pradhan D, Sharma A, Mohanty SK (2015) Cribriform-morular variant of papillary thyroid carcinoma. Pathol Res Pract 211:712–716CrossRef Pradhan D, Sharma A, Mohanty SK (2015) Cribriform-morular variant of papillary thyroid carcinoma. Pathol Res Pract 211:712–716CrossRef
19.
Zurück zum Zitat Hirokawa M, Maekawa M, Kuma S et al (2010) Cribriform-morular variant of papillary thyroid carcinoma–cytological and immunocytochemical findings of 18 cases. Diagn Cytopathol 38:890–896CrossRef Hirokawa M, Maekawa M, Kuma S et al (2010) Cribriform-morular variant of papillary thyroid carcinoma–cytological and immunocytochemical findings of 18 cases. Diagn Cytopathol 38:890–896CrossRef
20.
Zurück zum Zitat Lam AK, Saremi N (2017) Cribriform-morular variant of papillary thyroid carcinoma: a distinctive type of thyroid cancer. Endocr Relat Cancer 24:R109–R121CrossRef Lam AK, Saremi N (2017) Cribriform-morular variant of papillary thyroid carcinoma: a distinctive type of thyroid cancer. Endocr Relat Cancer 24:R109–R121CrossRef
21.
Zurück zum Zitat Chong Y, Shin JH, Oh YL et al (2013) Cribriform-morular variant of papillary thyroid carcinoma: ultrasonographic and clinical characteristics. Thyroid 23:45–49CrossRef Chong Y, Shin JH, Oh YL et al (2013) Cribriform-morular variant of papillary thyroid carcinoma: ultrasonographic and clinical characteristics. Thyroid 23:45–49CrossRef
22.
Zurück zum Zitat Nakazawa T, Celestino R, Machado JC et al (2013) Cribriform-morular variant of papillary thyroid carcinoma displaying poorly differentiated features. Int J Surg Pathol 21:379–389CrossRef Nakazawa T, Celestino R, Machado JC et al (2013) Cribriform-morular variant of papillary thyroid carcinoma displaying poorly differentiated features. Int J Surg Pathol 21:379–389CrossRef
23.
Zurück zum Zitat Cameselle-Teijeiro J, Menasce LP, Yap BK et al (2009) Cribriform-morular variant of papillary thyroid carcinoma: molecular characterization of a case with neuroendocrine differentiation and aggressive behavior. Am J Clin Pathol 131:134–142CrossRef Cameselle-Teijeiro J, Menasce LP, Yap BK et al (2009) Cribriform-morular variant of papillary thyroid carcinoma: molecular characterization of a case with neuroendocrine differentiation and aggressive behavior. Am J Clin Pathol 131:134–142CrossRef
Metadaten
Titel
Cribriform-Morular Variant of Papillary Thyroid Carcinoma: Clinical and Pathological Features of 30 Cases
verfasst von
Junko Akaishi
Tetsuo Kondo
Kiminori Sugino
Yuna Ogimi
Chie Masaki
Kiyomi Y. Hames
Tomonori Yabuta
Chisato Tomoda
Akifumi Suzuki
Kenichi Matsuzu
Takashi Uruno
Keiko Ohkuwa
Wataru Kitagawa
Mitsuji Nagahama
Ryohei Katoh
Koichi Ito
Publikationsdatum
25.04.2018
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 11/2018
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-018-4644-4

Weitere Artikel der Ausgabe 11/2018

World Journal of Surgery 11/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.